Babacan T - Search Results

1

Acute erythroid leukemia in a patient with chronic lymphocytic leukemia.

Guven DC, Babacan T, Sarici F, Akin S, Altundag K, Turker A. Guven DC, et al. Among authors: babacan t. J BUON. 2014 Oct-Dec;19(4):1127. J BUON. 2014. PMID: 25536628 No abstract available.

2

Successful treatment of myeloid sarcoma with local treatment modalities: the longest overall survival in published literature.

Aladag E, Babacan T, Akin S, Uner U, Kars A, Altundag K. Aladag E, et al. Among authors: babacan t. J BUON. 2014 Jan-Mar;19(1):316-7. J BUON. 2014. PMID: 24659682 No abstract available.

3

Colon involvement in a chronic lymphocytic leukemia patient.

Sarici F, Babacan T, Petekkaya I, Gezgen G, Roach EC, Altundag K. Sarici F, et al. Among authors: babacan t. J BUON. 2013 Jan-Mar;18(1):291-2. J BUON. 2013. PMID: 23613420 No abstract available.

4

A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.

Akin S, Babacan T, Sarici F, Altundag K. Akin S, et al. Among authors: babacan t. J BUON. 2014 Jan-Mar;19(1):42-6. J BUON. 2014. PMID: 24659641 Free article. Review.

5

Breast sarcoma: a rare malignancy.

Gul G, Babacan T, Akin S, Sarici F, Altundag K. Gul G, et al. Among authors: babacan t. J BUON. 2014 Apr-Jun;19(2):577. J BUON. 2014. PMID: 24965425 Free article. No abstract available.

6

Molecular subtypes in patients with inflammatory breast cancer; a single center experience.

Kertmen N, Babacan T, Keskin O, Solak M, Sarici F, Akin S, Arik Z, Aslan A, Ates O, Aksoy S, Ozisik Y, Altundag K. Kertmen N, et al. Among authors: babacan t. J BUON. 2015 Jan-Feb;20(1):35-9. J BUON. 2015. PMID: 25778293 Free article.

7

Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.

Ates O, Sunar V, Babacan T, Akin S, Kertmen N, Altundag K. Ates O, et al. Among authors: babacan t. J BUON. 2015 Jan-Feb;20(1):349. J BUON. 2015. PMID: 25778339 No abstract available.

8

Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis.

Babacan T, Buyukhatipoglu H, Balakan O, Kertmen N, Suner A, Sarici F, Akin S, Ates O, Karakas Y, Aslan A, Diker O, Altundag K. Babacan T, et al. J BUON. 2015 Mar-Apr;20(2):479-86. J BUON. 2015. PMID: 26011339 Free article.

9

Can aromatase inhibitors cause forgetfulness in women with breast cancer ?

Karatas F, Akin S, Babacan T, Sever AR, Altundag K. Karatas F, et al. Among authors: babacan t. J BUON. 2015 May-Jun;20(3):935. J BUON. 2015. PMID: 26214652 No abstract available.

10

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.

Ates O, Babacan T, Kertmen N, Sarici F, Cenoli A, Akin S, Karakas Y, Kilickap S, Ozisik Y, Sever AR, Aksoy S, Altundag K. Ates O, et al. Among authors: babacan t. J BUON. 2016 Mar-Apr;21(2):375-81. J BUON. 2016. PMID: 27273947 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters